Able to give written informed consent and comply with all study visits and procedures.

Patients and physicians must be willing to comply with treatment assignment:

The subject is willing and able to abide by the protocol

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations

Patients must be deemed able to comply with the treatment plan and follow-up schedule

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Participant is willing to comply with the protocol for the duration of the study, and undergo treatment and scheduled visits and examinations including follow up

Is willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related to food, drink and medications

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Subject has the willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Willing to comply with clinical trial instructions and requirements, including mandatory biopsies

Ability to comply with the study protocol, in the investigator's judgment

Patients must be deemed able to comply with the treatment plan and follow-up schedule

Ability and willingness to comply with the study protocol for the duration of the study and with follow-up procedures.

COHORT 1: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

COHORT 2: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Ability to understand and the willingness to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study, including disease assessment by MRI (or CT), as confirmed by signing a written informed consent document

Ability to comply with study procedures in the Investigator's opinion

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Must be able to comply with the treatment plan and follow-up schedule

Willing and able to comply with all aspects of the protocol

Subject should be able to provide written informed consent, comply with protocol visits and procedures, be able to take oral medication, and not have any active infection or comorbidity that would interfere with therapy.

Patients must be willing and able to complete all study procedures

Willingness and ability to comply with scheduled visits and study procedures

Patient able and willing to comply with study procedures as per protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.

Ability to understand and the willingness to sign a written informed consent document. Patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.

Willingness and ability to comply with scheduled visits, drug administration plan, protocol-specified laboratory tests, other study procedures, and study restrictions.

Psychiatric condition making the patient unlikely to comply with protocol therapy, required tests and follow-up.

Reliable and willing to make themselves available for the duration of the study and are willing to follow study-specific procedures.

Ability to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-up

Willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations, including follow-up

Be willing to comply with clinical trial instructions and requirements, including mandatory biopsies.

Patients >= 18 years must be willing to comply with the mandatory biopsies.

Patient must be willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.

Ability to understand and the willingness to sign a written informed consent document; subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Ability to comply with the study protocol, in the investigator's judgment

Willingness and ability to comply with study and follow-up procedures.

In the investigator’s judgment, the subject is unlikely to complete all protocol-required study visits or procedures, including follow-up visits, or comply with the study requirements for participation

Participant must be willing and able to comply with all aspects of the protocol

Willingness and ability to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Ability to understand and the willingness to sign a written informed consent document; patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations

Willingness and ability to comply with scheduled visits (including geographical distance), treatment plans, laboratory tests, and other study procedures.

Willingness and ability to comply with study and follow-up procedures

Ability to comply with the study protocol, in the investigator's judgment

Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required procedures.

Ability to understand and the willingness to sign a written informed consent document and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures.

Subject is willing and able to comply with scheduled visits, treatment plans, laboratory tests and other procedures (including bone marrow assessments).

As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Be willing and able to comply with scheduled visits, the treatment plan, imaging and laboratory tests

Willing and able to comply with the scheduled visits

Limitation of the patient's ability to comply with the treatment or follow-up protocol.

Ability to comply with the protocol

Subjects likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge

Ability to attend all scheduled study visits

Patients who cannot comply with protocol requirements including clinic visits for intravenous infusions and birth control measures may not be enrolled.

Willing and able to comply with scheduled visits, treatment plans, laboratory tests and procedures.

Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.

Subject is able to comply with study procedures and follow-up examinations

Willing and able to comply with the protocol, including follow-up visits and examinations

Patients must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study

Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.

Must be willing and able to accept at least three leukapheresis procedures

Patient must be able and willing to comply with study procedures as per protocol

Willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations with follow up.

Subjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and procedures

Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan, procedures, and laboratory testing

Willingness and ability to comply with study procedures and follow-up examination

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study, including disease assessment by magnetic resonance imaging (MRI).

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.

Willingness to give consent and comply with all study-related evaluations and treatment schedule; and

Signed informed consent and willingness/ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Able to understand the purpose and risks of the study; willing and able to adhere to scheduled visits, treatment plans, laboratory tests, and other study evaluations and procedures, and provide written informed consent

Participants must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study

Willingness and ability of the subject to comply with study activities.

Willingness and ability of the subject to comply with scheduled visits, drug administration plan, protocol-specified laboratory tests, other study procedures (including all bone marrow biopsy/aspirations and radiographic studies), and study restrictions.

Be willing to comply with treatment protocol

Ability to comply with the treatment schedule

Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirement

Patient must be willing to comply with all aspects of the protocol including completing the drug diary

Ability to comply with the study protocol, in the investigator's judgment

In the investigators judgment, the subject is unlikely to complete all protocol-required study visits or procedures, including follow-up visits, or comply with the study requirements for participation

Willingness and ability to comply with the trial and follow-up procedures.

Willingness and ability to comply with scheduled visit, treatment plans, laboratory tests, and other procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Ability and willingness to comply with all study requirements, including scheduled visits, treatment plans, laboratory tests, and other study-related procedures

Ability to comply with all study procedures and willingness to remain supine for 120 minutes during imaging

Subjects deemed unable to comply with study and/or follow-up procedures.

Ability to comply with the protocol

Stated willingness to comply with study procedures and duration.

Willing to travel to the NIH for follow-up visits

Patient is able and willing to comply with protocol and study procedures for the duration of the study including undergoing treatment and scheduled visits and examinations including follow-up visits

Willing and able to comply with the protocol, including follow-up visits and examinations

Willingness and ability to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

As determined by the enrolling physician or protocol designee, willingness and ability of the subject to understand and comply with study procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Willing and able to provide a signed and dated informed consent, comply with the study plan, follow up visits and phone calls

Be willing and have the ability to comply with scheduled visits (including geographical proximity), treatment plans, laboratory tests, and other study procedures

Participants must be willing to comply with all aspects of the protocol.

Must be willing and able to accept at least three leukapheresis procedures

In the investigators judgment, the subject is unlikely to complete all protocol required study visits or procedures, including follow up visits, or comply with the study requirements for participation

Ability to comply with the protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.

be willing and able to comply with study visits and procedures;

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Patients willing to comply with the clinical trial protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Ability to comply with the protocol

Willing and able to give informed consent and comply with all aspects of the protocol

Stated willingness to comply with all study procedures and be available for the duration of the trial

Ability and capacity to comply with the study and follow-up procedures

Patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study

Ability to comply with the protocol.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans, including willingness to take study medication, laboratory tests, and other study procedures

Must understand and be able, willing, and likely to fully comply with study procedures and restrictions.

Willingness and ability to comply with scheduled visits treatment plans, laboratory tests and other study procedures

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedure

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to complete study procedures within the study timelines

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study

Be willing to comply with treatment protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including biopsies and follow up.

Be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

CELL PROCUREMENT: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures

LYMPHODEPLETION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures

iC9-CAR19 CELL INFUSION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and biopsies as detailed in the protocol.

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study

Subject likely to not be available to complete all protocol required study visits or procedures to the best of the subject and investigator's knowledge

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures

Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty

Patients must be willing to travel to the study site for follow-up visits

Presence of psychiatric or neurologic disease, or lack of social support that limits patient's ability to comply with the treatment protocol including supportive care, follow-up, and research tests

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to comply with required scheduled visits and study procedures.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subject is willing and able to comply with all protocol required visits and assessments.

Patients must be willing and able to comply with scheduled visits, treatment and assessments

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Must be willing and able to accept two leukapheresis procedures

PHASE I: Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans, including willingness to take axitinib, laboratory tests, and other study procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures

Be able and willing to comply with study visits and procedures

Patients must express willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patients must be willing and able to comply with scheduled visits, treatment plan, and laboratory tests and accessible for follow-up.

Able to give written informed consent and comply with all study visits and procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Patient must be willing and able to comply with scheduled visits, treatment plan, and laboratory tests

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.

For the patient or parent/legal guardian to be able to comply with treatment plan, study procedures and follow-up examinations

Ability to understand and willingness for follow-up visits.

Willingness and ability to comply with all study procedures and able to take oral medications

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, imaging studies, and other requirements of the study

Ability to understand and the willingness to sign a written informed consent document and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures

The subject is willing and able to comply with the protocol, and agrees to return to the hospital for follow?up visits and examination

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

Subject must be able to provide written informed consent, comply with protocol visits and procedures, and take oral medication, and does not have any active infection or comorbidity that would interfere with therapy

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Willing to comply with scheduled visits and procedures

Ability to comply with the treatment schedule

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with study procedures and follow-up examinations

Be willing and able to comply with scheduled visits, the treatment plan, and laboratory tests

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures

Ability to understand and comply with study procedures for the entire length of the study as determined by the site investigator or protocol designee

Comply with study procedures and site visits

Ability to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-up

Be willing and able to comply with this protocol

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to comply with the protocol, scheduled follow-up, and management of toxicity as judged by the Investigator. Cohort 3B (Combination Expansion): Osteosarcoma subjects who progressed in Cohorts 1 or 2B and opt to receive combination therapy.

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.

Willing and able to comply with all study procedures

Ability to comply with the protocol

Must be willing and able to comply with study

Willing and able to comply with the protocol, including follow-up visits and examinations

Patient is willing to comply with protocol requirements and procedures, and keep scheduled study visits

Subject is able to provide written informed consent, comply with protocol visits and procedures, and take oral medication, and does not have any active infection or comorbidity that would interfere with therapy.

Patients must be capable of giving informed consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

Ability to comply with study and follow-up procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Participant must be willing to comply with study and/or follow-up procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Patient is willing and able to comply with protocol required assessments and procedures

Be able to comply with study procedures and follow-up examinations

Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures

Must be willing and able to accept at least two leukapheresis procedures

COHORTS 1 AND 2: HEALTHY VOLUNTEERS: Subjects must participate fully and be willing to comply with the procedures of the protocol

Patients willing and able to comply with the study protocol for the duration of the study

Willing to comply with study procedures

Willingness and ability to comply with scheduled visits, drug administration plan, laboratory tests,\r\nother study procedures, and study restrictions

Able and willing to comply with testing and treatment as outlined in this protocol

Willingness to comply with study guidelines

Subject is willing and able to comply with all protocol required visits and assessments, including biopsy if assigned.

Willing and able to comply with clinic visits and study-related procedures

Patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.

Ability to understand and the willingness to sign a written informed consent document; subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures.

Willing and able to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions including mandatory prophylaxis for Pneumocystis jirovecii pneumonia (PJP)

Must be available during the duration of the study and willing to follow the study procedures

Patient is currently enrolled in a Novartis-sponsored, Oncology Clinical Development & Medical Affairs study receiving imatinib and has fulfilled all their requirements in the parent study. 2.Patient is currently benefiting from the treatment with imatinib, as determined by the investigator. 3. Patient has demonstrated compliance, as assessed by the investigator, with the parent study protocol requirements.4. Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures. 5. Written informed consent obtained prior to enrolling in roll-over study.

Patients who cannot comply with medications

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Patients who are able and willing to give consent and able to attend all study visits

Patient able and willing to comply with study procedures as per protocol

Ability to comply with the protocol procedures (including geographic accessibility)

Patients must be able to comply with the protocol treatments and procedures.

Have the ability to understand and comply with the requirements and follow-up time points of the study

Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.

Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty

Subjects who are willing and able to comply with scheduled visits, treatment plans, laboratory tests, and procedures.

223 Subjects likely to not be available to complete all protocol- required study visits or procedures including BM aspirates/biopsies, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.

Willingness and ability to comply with study and follow-up procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations

Willingness to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions; psychological, social, familial or geographical factors that might preclude adequate study participation should be considered

Subject is willing and able to comply with the protocol for the duration of the study

Willingness and ability to comply with study and follow-up procedures.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory and radiographic assessments, and other study procedures, including ability to swallow study drug tablets and long-term follow-up

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and exams including follow up

Patient is able and willing to comply with protocol and study procedures for the duration of the study including undergoing treatment and scheduled visits and examinations including follow-up visits

Subjects is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee

Are able and willing to comply with all study procedures.

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty.

Subject must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Able to comply with the protocol, including tissue and blood sampling

Have the willingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.

The subject must be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.

State willingness to comply with all study procedures and be available for the duration of the trial

Participants must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patient must be able and willing to comply with study procedures as per protocol

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willingness and ability to comply with scheduled visits, drug administration plan,\n             laboratory tests, other study procedures, and study restrictions

Willingness and ability to comply with scheduled visits, treatment plans, laboratory\n             tests, and other study procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures

Emotional limitations, which the investigator judges could limit the patient's ability to follow up and comply with study procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations

Patients who, for medical or other reasons, are unable to comply with the study procedures

Able and willing to comply with study criteria

Willing and able to comply with all study procedures

Willing and able to comply with study procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests, including biopsies

Willing and able to comply with follow-up schedule

Willingness and ability to consent for self and to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Limitation of the patient's ability to comply with the treatment or to follow-up the protocol.

Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.

Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject's and investigator's knowledge.

Have the willingness and ability to comply with scheduled visit and study procedures.

Ability and willingness to comply with scheduled visits, treatment plan, laboratory assessments and other study procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Patients must comply with the treatment plan and follow-up schedule.

Ability to comply with the study protocol, in the investigator’s judgment

Limitation of the patient's ability to comply with the treatment or follow-up requirements.

Subject is willing and able to comply with all protocol required visits and assessments, including biopsy if assigned to the MTD expansion cohort;

Participant must be willing and able to comply with all aspects of the protocol.

Willing to comply with study procedures

Be willing and able to comply with all aspects of the protocol

Subjects must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Must be willing and able to accept two leukapheresis procedures

Is willing to and able to comply with scheduled visits and study procedures.

Willing and able to comply with all aspects of the protocol

Patient is willing and able to give consent and attend all study visits as defined in the protocol

Must be willing and able to accept at least two leukapheresis procedures

Willing and able to comply with all aspects of the treatment protocol

Subjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and procedures

Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

As determined by the enrolling physician or protocol designee, the subject should be able to understand and comply with study procedures for the entire length of the study

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Signed informed consent and willingness/ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Ability to comply with study procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures

Must be willing and able to comply with study visits and procedures.

Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study

Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty

Patient must be able to give informed consent and comply with the treatment protocol and follow-up plan.

Available for the duration of the study and are willing to follow study-specific procedures.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.

Willingness to comply with all study interventions and follow-up procedures

Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty

Patients must provide signed, written, informed consent and be willing and able to comply with eligibility requirements, scheduled, visits, and follow-up studies

Subjects must give informed consent and must be willing and able to comply with the scheduled visits, treatment plans, laboratory tests, and other procedures

Patients must be willing to travel to the study site for follow-up visits

The patient is able and willing to comply with all study related procedures

Willingness and ability to comply with study and follow-up procedures.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Have the willingness and ability to comply with scheduled visits and study procedures.

Subjects deemed unable to comply with study and/or follow-up procedures

Patient must be willing to comply with study procedures

Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.

As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Be willing and able to comply with the treatment plan, scheduled clinic visits, laboratory and oncological tests and other study procedures

Patients are willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations, and completing PRO instruments.

Ability and willingness to follow the guidelines of the clinical protocol including visits to National Institute of Child Health and Human Development (NICHD) and NCI, Bethesda, Maryland for treatment and follow up visits

Willing and able to comply with clinic visits and study-related procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.

Is able and willing to follow all study procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Patients must be willing and able to comply with study and/or follow-up procedures

Willing and able to comply with all aspects of the protocol

Willing to travel to the NIH for follow-up visits

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willing and able to comply with the protocol, including follow-up visits and examinations.

Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing

Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol

Be able to comply with treatment plan, study procedures and follow-up examinations

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

able to comply with all study-related procedures, medication use, and evaluations.

Patient is able to comply with all study procedures including study drug administration, visits and tests

Able to comply with scheduled follow-up and with management of toxicity

Patient must be willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Able to comply with scheduled follow-up and with management of toxicity.

Subject agrees to comply with follow up visits

Patients must be willing to comply with effective Antiretroviral Therapy.

Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol

Subject's willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures

Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures

Ability to comply with study procedures, in the Investigator's opinion

Subject must be willing and able to comply with all aspects of the protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to understand the nature of this study and to comply with the study and follow-up procedures.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patients who are not able to comply with study and/or follow up procedures

Ability to understand and the willingness to sign a written informed consent and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations; and

Be willing and have the ability to comply with scheduled visits (including geographical proximity), treatment plans, laboratory tests, and other study procedures

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures

Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Stated willingness of patient to comply with study procedures and reporting requirements.

Be willing to comply with the protocol.

Willingness to comply with scheduled visits, drug administration plan, protocol-specified bone marrow biopsies;

Willing to comply with study procedures and follow-up

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Participant must be willing to comply with study and/or follow-up procedures

Patients must be willing to comply with study procedures

Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty

Be able to comply with study procedures and follow-up examinations

Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Willingness and ability to comply with study and followup procedures.

Willingness and ability to comply with study and follow-up procedures

Patients (or guardians/parents) who are able and willing to give consent (and assent where applicable) and able to attend all study visits

Ability to understand and the willingness to sign a written informed consent document and follow the guidelines of the clinical protocol including visits to National Cancer Institute (NCI), Bethesda, Maryland for treatment and follow up visits

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Anticipated non-availability for study visits/procedures

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other study obligations

Be willing and able to comply with the protocol

Willing and able to comply with all aspects of the treatment protocol.

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Ability and willingness to comply with study visits, treatment, testing, and to comply with the protocol, in the investigator's judgment

Patient must be willing and able to comply with the study procedures and visit schedules and must be able to follow verbal and written instructions.

Willing and able to comply with scheduled visits, study assessments and laboratory tests, and other study procedures

Patients must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study.

Willing to give consent and comply with study-related evaluation and treatment schedule; and

Patient able and willing to comply with study procedures as per protocol, including the geriatric assessment at the time of study enrollment

Willingness to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions

Ability to comply with the protocol

Subject must be willing to comply with all procedures and assessments.

Willing and able to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions including mandatory prophylaxis for pneumocystis jiroveci pneumonia (PJP)

Able and willing to comply with all study procedures.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other trial procedures

Patient must be willing and able to comply with the protocol for the duration of the study, including attending scheduled visits, examinations, the biopsy procedure, and having their tumor and blood molecularly characterized

Subject should be able to provide written informed consent and comply with protocol visits and procedures.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Is the subject willing and able to abide by the protocol?

Unwillingness or inability to comply with scheduled visits, drug administration plan, laboratory tests, other study procedures, and study restrictions.

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures, including thrombokinetic studies and platelet function studies

Anticipated non-availability for study visits/procedures.

Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures

Reliable and available for the duration of the study and willing to follow study procedures.

Ability and willingness to follow the guidelines of the clinical protocol including visits to NCI, Bethesda, Maryland for treatment and follow up visits

Willing to comply with study procedures and follow-up

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Willing and able to comply with the protocol guidelines for the duration of the study

Willingness and ability to comply with all study procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures

Patient is willing and able to take oral medications and to comply with scheduled visits, treatment plan, and study related procedures

Understands and accepts the obligation and is logistically able to present for all scheduled follow-up visits.

Willing and able to comply with the protocol, including follow-up visits, examinations as well as having the ability to self-report pain and fatigue using a Patient-Reported Outcome (PRO) instrument

Patients who are able and willing to give consent and able to attend all study visits

201 Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.

Patients who are not able to comply with study and/or followup procedures

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures

Willing and able to comply with scheduled visits, treatment plan and laboratory tests

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Ability and capacity to comply with study and follow-up procedures

Subject agrees to comply with follow-up procedures, including returning for all follow-up visits

Ability to understand study procedures and to comply with them for the entire length of the study

Must be able to comply with follow up visits

Willing and able to comply with all aspects of study procedures

Be willing and able to adhere to all study-related procedures

Able and willing to comply with all study related procedures

Willing and able to undergo study assessment

Willing to comply with study procedures and reporting requirements

Not willing to comply with study procedures and reporting requirements

Subject is willing and able to comply with the follow-up regimen

Subject is willing and able to meet study requirements, including follow up visits

Willing to comply with all study procedures and be available for the duration of the study.

Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT

Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT

Willing to comply with study procedures and reporting requirements

Not willing to comply with study procedures and reporting requirements

Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT

Patients must be willing to comply with the study procedures and visits

Subjects, who in the opinion of the investigator, may not be able to comply with study procedures

Have visits planned with the oncology physician for at least 3 months and be willing to come in for study visits

Be able to understand study procedures and comply with them for the entire length of the study period

Ability to understand and comply with study procedures for the entire length of the study

Participant is willing and able to comply with the protocol for the duration of the study including undergoing treatment, scheduled visits, and examinations

Ability to comply with study procedures for the entire length of the study

Be willing and able to comply with the treatment plan, scheduled clinic visits, laboratory tests and other study procedures

The subject is able to complete the study and comply with study instructions, including attending all study visits

Is willing and able to comply with study instructions and commit to all clinic visits for the duration of the study

Subject is willing and able to provide written informed consent. 5. Subject is willing and able to meet all study requirements, including follow-up visits and receiving study-related telephone calls.

Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study

Subject is willing and able to comply with all protocol required visits and assessments;

Patients must be deemed able to comply with the treatment plan and follow-up schedule

Participants must be willing and able to comply with scheduled visits and imaging procedures in the opinion of the investigator or treating physician

Any patients who are unable to comply with the study procedures as determined by the study investigators

Ability to understand and comply with study guidelines

Investigator has concerns regarding the ability of the subject to give written informed consent and/or to comply with study procedures (including availability for follow up visits).

Subject is willing and able to comply with all aspects of the treatment and evaluation schedule.

The subject is willing and able to comply with the study protocol

Ability to understand study procedures and to comply with them for the entire length of the study

The subject is willing to comply with 30-day follow-up in the office and answer quality-of-life questionnaires per protocol

The subject is willing to comply with 90-day follow-up by phone

The subject is not willing to comply with 60-day follow-up in the office and answer quality-of-life questionnaires per protocol

The subject is not willing to comply with 90-day follow-up by phone

Subject agrees to comply with the study requirements and agrees to come to the clinic for required study visits

Willingness to comply with all study interventions of acupuncture and follow-up assessments

Participant is willing to be randomized and able to comply with the protocol

Willingness and ability to sign an IRB/IEC approved ICF before performance of any study specific procedures or tests and to comply with protocol visits, and study procedures.

Willing and able to comply with trial protocol and follow-up

Willingness to comply with study guidelines

Willing and able to comply with trial protocol and follow-up

Willingness to comply with all study interventions and follow-up procedures

Willing and able to comply with trial protocol and follow-up

RECIPIENT: Participant must be willing to comply with study and/or follow?up procedures, including willingness to be followed for one year post?HCT

Willingness to comply with all study interventions and follow-up procedures including the ability to apply the study drug to the breast

Willing to complete all study visits

Willing and able to comply with trial protocol and follow-up

Willingness to comply with all treatment and follow up procedures

Subjects, who, in the opinion of the clinical Investigator, are able to understand this clinical investigation, cooperate with the investigational procedures and are willing to return for all the required post-treatment follow-up visits

Subjects who are willing to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

Participant is willing to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

Patient is willing and able to give consent attend all study visits and complete all questionnaires as defined in the protocol

Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up

As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study

Willingness to comply with all study interventions and follow-up procedures including the ability to swallow the study drug

Willingness to comply with study guidelines

Willing to complete all study visits

Patients who are not able to comply with study and/or follow-up procedures

Stated willingness to comply with all required (non-optional) study procedures and be available for the duration of the study

Be willing and able to comply with scheduled visits, treatment plan, and MR imaging

Be conscious and able to comply with study procedures

Subject must be willing to comply with all clinical study procedures

Willingness to comply with the study protocol

Willing to comply with all study procedures and be available for the duration of the study

Subjects must be willing and able to comply with all procedures and visits required for this protocol (pre-treatment, during treatment, and post-treatment)

PATIENT: Be able to comply with study procedures

Subject deemed unlikely to be able to comply with instructions during imaging

Patients must be willing and able to be compliant with all procedures and visits required for this protocol (pre-treatment, during treatment, and optionally throughout follow-up period)

Willing and able to comply with scheduled visits and serial imaging procedures

Ability and willingness to comply with the study procedures

Able to understand, follow written instruction and willing to participate in all visits without rescheduled more than one or missed a visit without cancellation or rescheduling (no show)

Are willing and able to complete all procedures and assessments in accordance with the clinical protocol; and,

Must be able to understand and comply with study procedures for the entire length of the study

Willing to comply with all study procedures and be available for the duration of the study.

Patient is not likely to comply with the follow-up evaluation schedule

Able to provide written informed consent, comply with protocol visits and procedures, be able to take oral medication, and not have any active infection or comorbidity that would interfere with therapy.

Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol.

Ability and willingness to comply with all study requirements, including scheduled visits, treatment plans, laboratory tests, and other study-related procedures

Patients who are unable to comply with study and/or follow up procedures

The patient is willing and able to comply with the study protocol

Be capable of providing informed consent and demonstrate a willingness to comply with all the study procedures and visits

Eligible subjects must be able and willing to undergo the procedures of the study

Be willing and able to comply with scheduled visits and other trial procedures

Willing and able to undergo all study procedures

Be willing and able to comply with scheduled visits and other trial procedures

Willing and able to comply with all aspects of the protocol.

Capable and willing to comply with the entire study protocol

Patients not able to comply with the study procedures

Able to comply with protocol visits and procedures

Are willing and able to comply with study procedures and instructions, including completion of diaries.

Willing and able to comply with all study procedures

Patient is not likely to comply with the follow-up evaluation schedule

Able and willing to follow study procedures and instructions.

Limitation of the patient's ability to comply with the treatment or follow-up protocol.

Able and willing to follow study procedures and instructions.

Available for all study visits and able to comply with all study requirements.

Subjects must be able and willing to follow study procedures and instructions.

Able and willing to complete the entire study

Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Subjects unable to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures

Willingness and ability to comply with the trial and follow-up procedures.

Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.

Patient must be able to take oral medication and comply with protocol procedures and scheduled visits

Able and willing to complete the entire study

Participants must be willing and able to comply with all aspects of the protocol.

Note: Abstinence is acceptable if this is the usual lifestyle and preferred contraception for the subject; as determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study

Willingness and ability to comply with study procedures

As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study